Kyoichi Totsuka
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 10
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 5
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 18
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 26
-
- Pneumonia and Respiratory Infections 19
- Infective Endocarditis Diagnosis and Management 5
-
- Streptococcal Infections and Treatments 12
- Neonatal and Maternal Infections 5
Kyoichi Totsuka
71 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Molecular Medicine 319
- Clinical Biochemistry 308
- Applied Microbiology and Biotechnology 72
- Infectious Diseases 642
- Pharmacology 443
Countries citing papers authored by Kyoichi Totsuka
This map shows the geographic impact of Kyoichi Totsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoichi Totsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoichi Totsuka more than expected).
Fields of papers citing papers by Kyoichi Totsuka
This network shows the impact of papers produced by Kyoichi Totsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoichi Totsuka. The network helps show where Kyoichi Totsuka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kyoichi Totsuka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2014 | 45 | |
| 3 | 2014 | 6 | |
| 4 | 2013 | 1 | |
| 5 | 2010 | 3 | |
| 6 | An open clinical study of tebipenem pivoxil in children with acute otitis media and acute upper respiratory tract infection (phase II) | 2009 | 1 |
| 7 | Population pharmacokinetics and pharmacodynamics of 500 mg oral dose levofloxacin in respiratory tract infection patients | 2009 | 4 |
| 8 | An open clinical study of tebipenem pivoxil in children with bacterial pneumonia | 2009 | 3 |
| 9 | A open clinical trial study of tebipenem pivoxil fine granule for treatment of pediatric patients with otorlaryngological infections | 2009 | 1 |
| 10 | [The comparison of optimized pharmacodynamic dosing strategy for meropenem using Monte Carlo simulation]. | 2005 | 8 |
| 11 | 2005 | 101 | |
| 12 | 2003 | 6 | |
| 13 | 2001 | 8 | |
| 14 | 1993 | 1 | |
| 15 | Plasma concentration of teicoplanin in patients | 1993 | 1 |
| 16 | Basic and clinical evaluation of a carbapenem, meropenem | 1992 | 2 |
| 17 | STUDY ON POSTANTIBIOTIC EFFECT (PAE) OF PANIPENEM/BETAMIPRON, A CARBAPENEM ANTIBIOTIC | 1991 | 1 |
| 18 | 1991 | 2 | |
| 19 | Postantibiotic effect of fleroxacin, A new quinolone drug | 1990 | 1 |
| 20 | 1989 | 2 |
About Kyoichi Totsuka
Kyoichi Totsuka is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases, having authored 73 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (26 papers), Pneumonia and Respiratory Infections (19 papers), Antimicrobial Resistance in Staphylococcus (18 papers), Streptococcal Infections and Treatments (12 papers), Antibiotic Resistance in Bacteria (10 papers), Neonatal and Maternal Infections (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Infective Endocarditis Diagnosis and Management (5 papers). The work is most often cited by research in Molecular Medicine (319 citations), Clinical Biochemistry (308 citations) and Applied Microbiology and Biotechnology (72 citations). Kyoichi Totsuka has collaborated with scholars based in Japan, Pakistan and United States. Frequent co-authors include Ken Kikuchi, J. E. Leggett, B. Fantin, William A. Craig, Wim Calame, Steven C. Ebert, Bennett Vogelman, H. Mattie, Kihachiro Shimizu and Takehiko Uchiyama. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.